April 2024 updates to the website

The website has now been updated following April's LSCMMG

The following guidelines have been added/updated:

Out of area prescribing position statement - updated

Headache management guideline for adults - updated

Sodium zirconium cyclosilicate shared care - update to follow pending LMC approval

The following Items will be updated and added to the website following the next Clinical Effectiveness Group (CEG) / Commissioning Resource Group (CRG) Meeting:

Carbetocin - prevention of postpartum haemorrhage

Melatonin - sleep disturbance in adults with ADHD

Melatonin - for totally blind patients when started by a specialist and with clear review guidance

Melatonin - sleep problems in patients with dementia associated with Alzheimer’s

Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab - treating COVID-19 (NICE TA878)

Fluocinolone acetonide intravitreal implant - treating chronic diabetic macular oedema (NICE TA953)

Etrasimod - treating moderately to severely active ulcerative colitis in people aged 16 and over (NICE TA956)

Dupilumab - treating moderate to severe prurigo nodularis (NICE TA955)